Reuters logo
BRIEF-Replicel's phase 1 clinical trial for hair loss meets primary endpoints
March 14, 2017 / 10:21 AM / 6 months ago

BRIEF-Replicel's phase 1 clinical trial for hair loss meets primary endpoints

March 14 (Reuters) - Replicel Life Sciences Inc

* Replicel’s phase 1 clinical trial for hair loss succeeds in meeting primary endpoints

* Replicel life sciences - trial succesfully met its endpoints and sets stage for next steps in ongoing research and development of its product, rch-01 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below